Annual EBITDA
-$7.31 M
+$3.80 M+34.23%
30 June 2024
Summary:
Estrella Immunopharma annual earnings before interest, taxes, depreciation & amortization is currently -$7.31 million, with the most recent change of +$3.80 million (+34.23%) on 30 June 2024. During the last 3 years, it has fallen by -$6.58 million (-896.33%). ESLA annual EBITDA is now -896.33% below its all-time high of -$733.70 thousand, reached on 30 June 2021.ESLA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$3.38 M
+$572.70 K+14.50%
30 September 2024
Summary:
Estrella Immunopharma quarterly earnings before interest, taxes, depreciation & amortization is currently -$3.38 million, with the most recent change of +$572.70 thousand (+14.50%) on 30 September 2024. Over the past year, it has dropped by -$1.51 million (-80.52%). ESLA quarterly EBITDA is now -3088.57% below its all-time high of -$105.90 thousand, reached on 01 December 2021.ESLA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$8.82 M
-$1.51 M-20.60%
30 September 2024
Summary:
Estrella Immunopharma TTM earnings before interest, taxes, depreciation & amortization is currently -$8.82 million, with the most recent change of -$1.51 million (-20.60%) on 30 September 2024. Over the past year, it has increased by +$1.28 million (+12.66%). ESLA TTM EBITDA is now -8225.02% below its all-time high of -$105.90 thousand, reached on 01 December 2021.ESLA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESLA EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.2% | -80.5% | +12.7% |
| 3 y3 years | -896.3% | - | - |
| 5 y5 years | - | - | - |
ESLA EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -896.3% | +34.2% | -3088.6% | +14.5% | -8225.0% | +20.6% |
| 5 y | 5 years | -896.3% | +34.2% | -3088.6% | +14.5% | -8225.0% | +20.6% |
| alltime | all time | -896.3% | +34.2% | -3088.6% | +14.5% | -8225.0% | +20.6% |
Estrella Immunopharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.38 M(-14.5%) | -$8.82 M(+20.6%) |
| June 2024 | -$7.31 M(-34.2%) | -$3.95 M(+741.2%) | -$7.31 M(+20.0%) |
| Mar 2024 | - | -$469.50 K(-54.0%) | -$6.09 M(-27.1%) |
| Dec 2023 | - | -$1.02 M(-45.4%) | -$8.36 M(-17.2%) |
| Sept 2023 | - | -$1.87 M(-31.5%) | -$10.09 M(-9.1%) |
| June 2023 | - | -$2.73 M(-0.1%) | -$11.11 M(+17.5%) |
| June 2023 | -$11.11 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$2.74 M(-0.8%) | -$9.45 M(+37.3%) |
| Dec 2022 | - | -$2.76 M(-4.5%) | -$6.88 M(+62.6%) |
| Sept 2022 | - | -$2.89 M(+168.6%) | -$4.23 M(+214.0%) |
| June 2022 | - | -$1.07 M(+538.3%) | -$1.35 M(+391.8%) |
| June 2022 | -$1.69 M(+129.7%) | - | - |
| Mar 2022 | - | -$168.30 K(+58.9%) | -$274.20 K(+158.9%) |
| Dec 2021 | - | -$105.90 K | -$105.90 K |
| June 2021 | -$733.70 K | - | - |
FAQ
- What is Estrella Immunopharma annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Estrella Immunopharma?
- What is Estrella Immunopharma annual EBITDA year-on-year change?
- What is Estrella Immunopharma quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Estrella Immunopharma?
- What is Estrella Immunopharma quarterly EBITDA year-on-year change?
- What is Estrella Immunopharma TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Estrella Immunopharma?
- What is Estrella Immunopharma TTM EBITDA year-on-year change?
What is Estrella Immunopharma annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ESLA is -$7.31 M
What is the all time high annual EBITDA for Estrella Immunopharma?
Estrella Immunopharma all-time high annual earnings before interest, taxes, depreciation & amortization is -$733.70 K
What is Estrella Immunopharma annual EBITDA year-on-year change?
Over the past year, ESLA annual earnings before interest, taxes, depreciation & amortization has changed by +$3.80 M (+34.23%)
What is Estrella Immunopharma quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ESLA is -$3.38 M
What is the all time high quarterly EBITDA for Estrella Immunopharma?
Estrella Immunopharma all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$105.90 K
What is Estrella Immunopharma quarterly EBITDA year-on-year change?
Over the past year, ESLA quarterly earnings before interest, taxes, depreciation & amortization has changed by -$1.51 M (-80.52%)
What is Estrella Immunopharma TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ESLA is -$8.82 M
What is the all time high TTM EBITDA for Estrella Immunopharma?
Estrella Immunopharma all-time high TTM earnings before interest, taxes, depreciation & amortization is -$105.90 K
What is Estrella Immunopharma TTM EBITDA year-on-year change?
Over the past year, ESLA TTM earnings before interest, taxes, depreciation & amortization has changed by +$1.28 M (+12.66%)